TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.80
-0.45 (-3.67%)
Mar 4, 2026, 12:19 PM CST

TPEX:4157 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8,7208,21910,91111,50511,03916,380
Market Cap Growth
11.44%-24.67%-5.16%4.22%-32.60%24.19%
Enterprise Value
7,9407,22210,16910,54510,03215,984
Last Close Price
12.2511.4515.2016.0515.4022.85
PE Ratio
--79.80-14.23-
PS Ratio
225.0554.5688.61317.568.53699.34
PB Ratio
9.777.599.7511.868.8137.04
P/TBV Ratio
9.777.689.8711.868.8137.07
P/FCF Ratio
363331.72-3055.51-17.84-
P/OCF Ratio
17474.87-1462.83-17.55-
EV/Sales Ratio
204.9147.9482.59291.057.75682.43
EV/EBITDA Ratio
----11.03-
EV/EBIT Ratio
----11.15-
EV/FCF Ratio
330815.10-2847.73-16.21-
Debt / Equity Ratio
0.090.050.070.040.040.04
Debt / EBITDA Ratio
----0.06-
Debt / FCF Ratio
3395.79-20.92-0.09-
Net Debt / Equity Ratio
-0.87-0.89-0.86-0.89-0.69-0.71
Net Debt / EBITDA Ratio
4.668.455.853.22-0.961.06
Net Debt / FCF Ratio
-32516.625.54-269.7634.88-1.411.27
Asset Turnover
0.040.130.110.031.330.03
Inventory Turnover
0.370.420.460.230.780.36
Quick Ratio
9.9922.4922.3817.9713.413.86
Current Ratio
10.7923.5723.1918.5013.714.13
Return on Equity (ROE)
-18.36%-3.51%13.09%-21.33%91.47%-64.39%
Return on Assets (ROA)
-9.62%-6.35%-9.59%-14.23%57.68%-25.57%
Return on Invested Capital (ROIC)
-134.26%-88.22%-125.41%-112.72%311.53%-165.06%
Return on Capital Employed (ROCE)
-18.60%-10.80%-14.80%-27.90%69.00%-66.60%
Earnings Yield
-2.11%-0.47%1.25%-2.06%7.03%-2.47%
FCF Yield
0.00%-2.11%0.03%-0.21%5.61%-1.51%
Buyback Yield / Dilution
0.06%-0.03%-0.06%0.07%-0.07%-0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.